AVNS Q2 2024 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$172M+1.4% YoY

Gross Profit

$96M55.7% margin

Operating Income

$16M9.4% margin

Net Income

$2M1.0% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

$22M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$436M

Stockholders' Equity

$1.2B

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$172M	$169M	+1.4%
Gross Profit	$96M	$98M	-2.2%
Operating Income	$16M	$12M	+36.4%
Net Income	$2M	-$68M	+102.6%

Revenue Segments

Digestive Health

$98M70%

Interventional pain

$42M30%